Clinical Trial Update: A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AVE5530 over 4 weeks in patients with mild to moderate hypercholesterolemia has completed. The update reports safety and efficacy fin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AVE5530

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED